Blood · 2017 · 80 citations · 20 references
MedicineMolecular BiologyOncologyMolecular OncologyOncogenesTranscriptional RegulationOncogene ActivationOncogene AmplificationOncogene MutationsOncogene OverexpressionPromoter RegulationProto-oncogene ActivationAcute Lymphoblastic Leukemia BiologyCellular OncogenesOncogene RegulationOncogenic Transcriptional NetworksOncogenic TransformationT-cell Acute Lymphoblastic LeukemiaTumor Promoter Mechanisms
expression, establishing clear causality between the mutation and oncogene dysregulation. Furthermore, the spectrum of CRISPR/Cas9-derived mutations provides important insights into the interconnected contributions of functional transcription factor binding. Finally, these mutations occur in the same intron as retroviral integration sites in gene therapy-induced T-ALL, suggesting that such events occur at preferential sites in the noncoding genome.
20
An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element
Marc R. Mansour, Brian J. Abraham, Lars Anders et al. · Science · 2014 · 818 citations · Full text
Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity
Christian Braun, Kaan Boztuǧ, Anna Paruzynski et al. · Science Translational Medicine · 2014 · 555 citations · Full text